Inari Medical, Inc. revised revenue guidance for the full year 2022. For the full year 2022, the company revising its revenue guidance to a range of $360 million to $370 million, an increase of $10 million from its original guidance range of $350 million to $360 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.75 USD | -1.19% | +4.57% | -29.53% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.53% | 2.66B | |
+73.24% | 12.39B | |
-19.09% | 7.89B | |
+5.88% | 6.59B | |
+13.24% | 5.43B | |
+38.48% | 4.96B | |
-17.30% | 4.72B | |
-19.78% | 4.02B | |
+47.29% | 2.37B | |
-2.10% | 1.96B |
- Stock Market
- Equities
- NARI Stock
- News Inari Medical, Inc.
- Inari Medical, Inc. Revises Revenue Guidance for the Full Year 2022